ArticleThe oncologist2024

Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.

Luca Boscolo Bielo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.